Read
Ingredients → Fluocinolone
Flcn
Topical Medication
C21H26F2O6
TARGETS:
Skin inflammation
BENEFITS:
→
Reduces the irritating effects of hydroquinone and tretinoin
2009
A Histological Examination for Skin Atrophy After 6 Months of Treatment With Fluocinolone Acetonide 0.01%, Hydroquinone 4%, and Tretinoin 0.05% Cream
...
The American Journal of Dermatopathology
2008
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma
...
British Journal of Dermatology
2005
Hydroquinone 4%, Tretinoin 0.05%, Fluocinolone Acetonide 0.01%: A Safe and Efficacious 12-Month Treatment for Melasma
...
Therapeutics For The Clinician
2004
Rationale for the use of topical corticosteroids in melasma.
Journal of Drugs in Dermatology
2003
Efficacy and Safety of a New Triple-Combination Agent for the Treatment of Facial Melasma
...
Therapeutics For The Clinician
SIDE EFFECTS
The following skin reactions have been observed with topical steroids: folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria. Risks are higher with prolonged use and with higher potency corticosteroids. A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of side effects and others may occur. Contact your dermatology provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Recommended Posts
Prescription vs. OTC: acne treatment
A winning combination: oral + topical treatment
Read
Doxycycline: an antibiotic for acne
Read